# AI development for breast cancer diagnostics

> Live situation record from CLSTR: https://clstr.news/situations/ai-development-for-breast-cancer-diagnostics
> Updated: 2026-10-12T05:58:34.000Z. Sources: 5. Developments: 2.

Researchers are developing artificial intelligence tools to improve breast cancer diagnosis and risk assessment. 

One new tool, IICM+, utilizes data from the TAILORx clinical study to predict long-term recurrence risks in patients with early-stage hormone receptor-positive, HER2-negative breast cancer, specifically targeting risks that emerge beyond a five-year window. 

In Mexico, researchers at the Instituto Politécnico Nacional (IPN) have developed a system to accelerate mammography analysis. This tool classifies studies into low, medium, or high-risk levels by combining medical imaging with clinical data, such as family history and hormone therapy, to help specialists prioritize urgent cases.

## Timeline

### 2026-10-12: IPN develops AI to detect breast cancer

IPN researchers developed an AI system to analyze mammographies and estimate breast cancer risk, helping specialists prioritize high-risk patients using clinical data and medical imaging.

2 sources. https://clstr.news/cluster/ipn-develops-ai-to-detect-breast-cancer

### 2026-10-04: Breast cancer: New AI tool predicts long-term recurrence risk

New AI tool IICM+ aims to predict long-term breast cancer recurrence beyond five years, while Greece hosts the 18th Race for the Cure to raise awareness for the 9,000 annual local diagnoses.

3 sources. https://clstr.news/cluster/breast-cancer-new-ai-tool-predicts-long-term-recurrence-risk

---
Cite as: AI development for breast cancer diagnostics. CLSTR, https://clstr.news/situations/ai-development-for-breast-cancer-diagnostics